Cite
Tau-PET and in vivo Braak-staging as prognostic markers of future cognitive decline in cognitively normal to demented individuals.
MLA
Biel, Davina, et al. “Tau-PET and in Vivo Braak-Staging as Prognostic Markers of Future Cognitive Decline in Cognitively Normal to Demented Individuals.” Alzheimer’s Research & Therapy, vol. 13, no. 1, Oct. 2021, pp. 1–13. EBSCOhost, https://doi.org/10.1186/s13195-021-00880-x.
APA
Biel, D., Brendel, M., Rubinski, A., Buerger, K., Janowitz, D., Dichgans, M., & Franzmeier, N. (2021). Tau-PET and in vivo Braak-staging as prognostic markers of future cognitive decline in cognitively normal to demented individuals. Alzheimer’s Research & Therapy, 13(1), 1–13. https://doi.org/10.1186/s13195-021-00880-x
Chicago
Biel, Davina, Matthias Brendel, Anna Rubinski, Katharina Buerger, Daniel Janowitz, Martin Dichgans, and Nicolai Franzmeier. 2021. “Tau-PET and in Vivo Braak-Staging as Prognostic Markers of Future Cognitive Decline in Cognitively Normal to Demented Individuals.” Alzheimer’s Research & Therapy 13 (1): 1–13. doi:10.1186/s13195-021-00880-x.